These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9640462)

  • 1. Immediate use of anticoagulants may not improve stroke outcomes.
    Am J Health Syst Pharm; 1998 Jun; 55(12):1240. PubMed ID: 9640462
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bounderies of the authorization to market and the therapeutic impass].
    Samama CM
    Ann Fr Anesth Reanim; 2001 Jun; 20(6):507-8. PubMed ID: 11471497
    [No Abstract]   [Full Text] [Related]  

  • 3. [Danaparoid for anticoagulation with Cell Saver 5. Answer to the letter of A. Lorentz].
    von Lüpke U
    Anaesthesist; 2001 Oct; 50(10):793. PubMed ID: 11702331
    [No Abstract]   [Full Text] [Related]  

  • 4. Fatal danaparoid-sodium induced thrombocytopenia and arterial thromboses.
    Tardy B; Tardy-Poncet B; Viallon A; Piot M; Mazet E
    Thromb Haemost; 1998 Sep; 80(3):530. PubMed ID: 9759647
    [No Abstract]   [Full Text] [Related]  

  • 5. [Is it safe and cost effective... Danaparoid (Orgaran) as an anticoagulant for mechanical autotransfusion with Cell Saver 5 (Hemonetics),Anaesthesist (2001) 50:26-31].
    Lorentz A
    Anaesthesist; 2001 Oct; 50(10):792. PubMed ID: 11702330
    [No Abstract]   [Full Text] [Related]  

  • 6. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators.
    JAMA; 1998 Apr 22-29; 279(16):1265-72. PubMed ID: 9565006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischemic stroke (Cochrane review).
    Counsell C; Sandercock P
    Stroke; 2002 Jul; 33(7):1925-6. PubMed ID: 12105377
    [No Abstract]   [Full Text] [Related]  

  • 8. Ardeparin and danaparoid for prevention of deep vein thrombosis.
    Med Lett Drugs Ther; 1997 Oct; 39(1011):94-5. PubMed ID: 9379998
    [No Abstract]   [Full Text] [Related]  

  • 9. Classification of subtypes of ischemic stroke: history of the trial of org 10172 in acute stroke treatment classification.
    Adams HP; Biller J
    Stroke; 2015 May; 46(5):e114-7. PubMed ID: 25813192
    [No Abstract]   [Full Text] [Related]  

  • 10. Delivery of a healthy child 30 weeks after resuscitation for thromboembolism and treatment with danaparoid: 5-year follow up.
    Weilbach C; Rahe-Meyer N; Raymondos K; Piepenbrock S
    J Perinat Med; 2006; 34(6):505-6. PubMed ID: 17140305
    [No Abstract]   [Full Text] [Related]  

  • 11. [Thromboembolytic complications. Alternative anticoagulation in HIT II].
    Anaesthesist; 2000 Dec; 49(12):1077. PubMed ID: 11202083
    [No Abstract]   [Full Text] [Related]  

  • 12. Ardeparin and danaparoid.
    Dimens Crit Care Nurs; 2000; 19(4):13-4. PubMed ID: 11998151
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of danaparoid during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia.
    Olin DA; Urdaneta F; Lobato EB
    J Cardiothorac Vasc Anesth; 2000 Dec; 14(6):707-9. PubMed ID: 11139115
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of heparin-induced thrombocytopenia.
    Peters FP
    J Thorac Cardiovasc Surg; 1997 Sep; 114(3):517-8. PubMed ID: 9305220
    [No Abstract]   [Full Text] [Related]  

  • 15. Danaparoid in the prevention of ischemic stroke in paroxysmal nocturnal hemoglobinuria.
    Zyss J; Cakmak S; Derex L; Michallet M; Nighoghossian N
    Cerebrovasc Dis; 2007; 23(5-6):462-3. PubMed ID: 17435387
    [No Abstract]   [Full Text] [Related]  

  • 16. [Danaparoid (orgaran) for continuous venovenous hemodiafiltration in a patient with heparin-induced thrombocytopenia].
    Christin F; Theissen-Laval O; Loeb JP
    Ann Fr Anesth Reanim; 1998; 17(1):82-3. PubMed ID: 9750692
    [No Abstract]   [Full Text] [Related]  

  • 17. [Danaparoid sodium].
    Kitazawa Y
    Rinsho Byori; 2011 Feb; Suppl 147():164-6. PubMed ID: 21761765
    [No Abstract]   [Full Text] [Related]  

  • 18. Danaparoid: a review of its use in thromboembolic and coagulation disorders.
    Ibbotson T; Perry CM
    Drugs; 2002; 62(15):2283-314. PubMed ID: 12381232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of Orgaran for extracorporeal circulation in a patient allergic to heparin].
    Bretelle C; Leude E; Quilici J; Vaillant A
    Presse Med; 1996 Nov; 25(37):1846-7. PubMed ID: 8991040
    [No Abstract]   [Full Text] [Related]  

  • 20. Safe anticoagulation with danaparoid in pregnancy and lactation.
    Schindewolf M; Mosch G; Bauersachs RM; Lindhoff-Last E
    Thromb Haemost; 2004 Jul; 92(1):211. PubMed ID: 15213864
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.